ID   GPX4_HUMAN              Reviewed;         197 AA.
AC   P36969; O43381; Q6PJ59; Q9UPK2;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   26-FEB-2008, sequence version 3.
DT   18-JUN-2025, entry version 232.
DE   RecName: Full=Phospholipid hydroperoxide glutathione peroxidase GPX4 {ECO:0000303|PubMed:36608588};
DE            Short=PHGPx;
DE            EC=1.11.1.12 {ECO:0000269|PubMed:11115402, ECO:0000269|PubMed:36608588};
DE   AltName: Full=Glutathione peroxidase 4 {ECO:0000303|PubMed:9705830};
DE            Short=GPx-4 {ECO:0000303|PubMed:9705830};
DE            Short=GSHPx-4 {ECO:0000303|PubMed:9705830};
DE            EC=1.11.1.9 {ECO:0000269|PubMed:36608588};
DE   Flags: Precursor;
GN   Name=GPX4 {ECO:0000303|PubMed:9705830, ECO:0000312|HGNC:HGNC:4556};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Testis;
RX   PubMed=8039723; DOI=10.1016/0378-1119(94)90400-6;
RA   Esworthy R.S., Doan K., Doroshow J.H., Chu F.-F.;
RT   "Cloning and sequencing of the cDNA encoding a human testis phospholipid
RT   hydroperoxide glutathione peroxidase.";
RL   Gene 144:317-318(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RX   PubMed=9705830; DOI=10.1006/bbrc.1998.9086;
RA   Kelner M.J., Montoya M.A.;
RT   "Structural organization of the human selenium-dependent phospholipid
RT   hydroperoxide glutathione peroxidase gene (GPX4): chromosomal localization
RT   to 19p13.3.";
RL   Biochem. Biophys. Res. Commun. 249:53-55(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ASN-2.
RG   NIEHS SNPs program;
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Eye, Lung, Pancreas, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=11115402;
RA   Sutherland M., Shankaranarayanan P., Schewe T., Nigam S.;
RT   "Evidence for the presence of phospholipid hydroperoxide glutathione
RT   peroxidase in human platelets: implications for its involvement in the
RT   regulatory network of the 12-lipoxygenase pathway of arachidonic acid
RT   metabolism.";
RL   Biochem. J. 353:91-100(2001).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   FUNCTION.
RX   PubMed=24439385; DOI=10.1016/j.cell.2013.12.010;
RA   Yang W.S., SriRamaratnam R., Welsch M.E., Shimada K., Skouta R.,
RA   Viswanathan V.S., Cheah J.H., Clemons P.A., Shamji A.F., Clish C.B.,
RA   Brown L.M., Girotti A.W., Cornish V.W., Schreiber S.L., Stockwell B.R.;
RT   "Regulation of ferroptotic cancer cell death by GPX4.";
RL   Cell 156:317-331(2014).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [11]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=36608588; DOI=10.1016/j.redox.2022.102593;
RA   Schwarz M., Loeser A., Cheng Q., Wichmann-Costaganna M., Schaedel P.,
RA   Werz O., Arner E.S., Kipp A.P.;
RT   "Side-by-side comparison of recombinant human glutathione peroxidases
RT   identifies overlapping substrate specificities for soluble
RT   hydroperoxides.";
RL   Redox Biol. 59:102593-102593(2023).
RN   [12]
RP   INTERACTION WITH FUNDC1.
RX   PubMed=36828120; DOI=10.1016/j.jare.2023.02.012;
RA   Bi Y., Liu S., Qin X., Abudureyimu M., Wang L., Zou R., Ajoolabady A.,
RA   Zhang W., Peng H., Ren J., Zhang Y.;
RT   "FUNDC1 interacts with GPx4 to govern hepatic ferroptosis and fibrotic
RT   injury through a mitophagy-dependent manner.";
RL   J. Adv. Res. 0:0-0(2023).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 29-197 (ISOFORM CYTOPLASMIC),
RP   SUBUNIT, MUTAGENESIS OF SEC-73, FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=17630701; DOI=10.1021/bi700840d;
RA   Scheerer P., Borchert A., Krauss N., Wessner H., Gerth C., Hoehne W.,
RA   Kuhn H.;
RT   "Structural basis for catalytic activity and enzyme polymerization of
RT   phospholipid hydroperoxide glutathione peroxidase-4 (GPx4).";
RL   Biochemistry 46:9041-9049(2007).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 36-197.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of the selenocysteine to glycine mutant of human
RT   glutathione peroxidase 4 (GPX4).";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [15] {ECO:0007744|PDB:5H5Q, ECO:0007744|PDB:5H5R, ECO:0007744|PDB:5H5S}
RP   X-RAY CRYSTALLOGRAPHY (1.10 ANGSTROMS) OF 29-197 OF MUTANT CYS-73.
RX   PubMed=27836545; DOI=10.1016/j.bbrc.2016.11.035;
RA   Sakamoto K., Sogabe S., Kamada Y., Matsumoto S.I., Kadotani A.,
RA   Sakamoto J.I., Tani A.;
RT   "Discovery of GPX4 inhibitory peptides from random peptide T7 phage display
RT   and subsequent structural analysis.";
RL   Biochem. Biophys. Res. Commun. 482:195-201(2017).
RN   [16]
RP   VARIANTS ASN-2 AND THR-120.
RX   PubMed=12606444; DOI=10.1095/biolreprod.102.007500;
RA   Maiorino M., Bosello V., Ursini F., Foresta C., Garolla A., Scapin M.,
RA   Sztajer H., Flohe L.;
RT   "Genetic variations of gpx-4 and male infertility in humans.";
RL   Biol. Reprod. 68:1134-1141(2003).
RN   [17]
RP   VARIANT SMDS 90-TYR--PHE-197 DEL, AND INVOLVEMENT IN SMDS.
RX   PubMed=24706940; DOI=10.1136/jmedgenet-2013-102218;
RG   FORGE Canada Consortium;
RA   Smith A.C., Mears A.J., Bunker R., Ahmed A., MacKenzie M.,
RA   Schwartzentruber J.A., Beaulieu C.L., Ferretti E., Majewski J.,
RA   Bulman D.E., Celik F.C., Boycott K.M., Graham G.E.;
RT   "Mutations in the enzyme glutathione peroxidase 4 cause Sedaghatian-type
RT   spondylometaphyseal dysplasia.";
RL   J. Med. Genet. 51:470-474(2014).
CC   -!- FUNCTION: Essential antioxidant peroxidase that directly reduces
CC       phospholipid hydroperoxide even if they are incorporated in membranes
CC       and lipoproteins (By similarity). Can also reduce cholesterol
CC       hydroperoxide and thymine hydroperoxide (By similarity). Plays a key
CC       role in protecting cells from oxidative damage by preventing membrane
CC       lipid peroxidation (By similarity). Required to prevent cells from
CC       ferroptosis, a non-apoptotic cell death resulting from an iron-
CC       dependent accumulation of lipid reactive oxygen species
CC       (PubMed:24439385). The presence of selenocysteine (Sec) versus Cys at
CC       the active site is essential for life: it provides resistance to
CC       overoxidation and prevents cells against ferroptosis (By similarity).
CC       The presence of Sec at the active site is also essential for the
CC       survival of a specific type of parvalbumin-positive interneurons,
CC       thereby preventing against fatal epileptic seizures (By similarity).
CC       May be required to protect cells from the toxicity of ingested lipid
CC       hydroperoxides (By similarity). Required for normal sperm development
CC       and male fertility (By similarity). Essential for maturation and
CC       survival of photoreceptor cells (By similarity). Plays a role in a
CC       primary T-cell response to viral and parasitic infection by protecting
CC       T-cells from ferroptosis and by supporting T-cell expansion (By
CC       similarity). Plays a role of glutathione peroxidase in platelets in the
CC       arachidonic acid metabolism (PubMed:11115402). Reduces hydroperoxy
CC       ester lipids formed by a 15-lipoxygenase that may play a role as down-
CC       regulator of the cellular 15-lipoxygenase pathway (By similarity). Can
CC       reduce fatty acid-derived hydroperoxides (PubMed:11115402,
CC       PubMed:36608588). Can also reduce small soluble hydroperoxides such as
CC       H2O2, cumene hydroperoxide and tert-butyl hydroperoxide
CC       (PubMed:17630701, PubMed:36608588). {ECO:0000250|UniProtKB:O70325,
CC       ECO:0000250|UniProtKB:P36968, ECO:0000269|PubMed:11115402,
CC       ECO:0000269|PubMed:17630701, ECO:0000269|PubMed:24439385,
CC       ECO:0000269|PubMed:36608588}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a hydroperoxy polyunsaturated fatty acid + 2 glutathione = a
CC         hydroxy polyunsaturated fatty acid + glutathione disulfide + H2O;
CC         Xref=Rhea:RHEA:19057, ChEBI:CHEBI:15377, ChEBI:CHEBI:57925,
CC         ChEBI:CHEBI:58297, ChEBI:CHEBI:131871, ChEBI:CHEBI:134019;
CC         EC=1.11.1.12; Evidence={ECO:0000269|PubMed:11115402,
CC         ECO:0000269|PubMed:36608588};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19058;
CC         Evidence={ECO:0000305|PubMed:36608588};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 glutathione + H2O2 = glutathione disulfide + 2 H2O;
CC         Xref=Rhea:RHEA:16833, ChEBI:CHEBI:15377, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:57925, ChEBI:CHEBI:58297; EC=1.11.1.9;
CC         Evidence={ECO:0000269|PubMed:36608588};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16834;
CC         Evidence={ECO:0000269|PubMed:36608588};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=tert-butyl hydroperoxide + 2 glutathione = tert-butanol +
CC         glutathione disulfide + H2O; Xref=Rhea:RHEA:69412, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:45895, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297,
CC         ChEBI:CHEBI:64090; Evidence={ECO:0000269|PubMed:17630701,
CC         ECO:0000269|PubMed:36608588};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69413;
CC         Evidence={ECO:0000269|PubMed:36608588};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=cumene hydroperoxide + 2 glutathione = 2-phenylpropan-2-ol +
CC         glutathione disulfide + H2O; Xref=Rhea:RHEA:69651, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:78673,
CC         ChEBI:CHEBI:131607; Evidence={ECO:0000269|PubMed:36608588};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69652;
CC         Evidence={ECO:0000269|PubMed:36608588};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9S)-hydroperoxy-(10E,12Z)-octadecadienoate + 2 glutathione =
CC         (9S)-hydroxy-(10E,12Z)-octadecadienoate + glutathione disulfide +
CC         H2O; Xref=Rhea:RHEA:76687, ChEBI:CHEBI:15377, ChEBI:CHEBI:57925,
CC         ChEBI:CHEBI:58297, ChEBI:CHEBI:60955, ChEBI:CHEBI:77852;
CC         Evidence={ECO:0000269|PubMed:36608588};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76688;
CC         Evidence={ECO:0000305|PubMed:36608588};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(13S)-hydroperoxy-(9Z,11E)-octadecadienoate + 2 glutathione =
CC         (13S)-hydroxy-(9Z,11E)-octadecadienoate + glutathione disulfide +
CC         H2O; Xref=Rhea:RHEA:48888, ChEBI:CHEBI:15377, ChEBI:CHEBI:57466,
CC         ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:90850;
CC         Evidence={ECO:0000269|PubMed:36608588};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48889;
CC         Evidence={ECO:0000305|PubMed:36608588};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5S)-hydroperoxy-(6E,8Z,11Z,14Z)-eicosatetraenoate + 2
CC         glutathione = (5S)-hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoate +
CC         glutathione disulfide + H2O; Xref=Rhea:RHEA:48620, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:57450, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297,
CC         ChEBI:CHEBI:90632; Evidence={ECO:0000269|PubMed:36608588};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48621;
CC         Evidence={ECO:0000305|PubMed:36608588};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(12R)-hydroperoxy-(5Z,8Z,10E,14Z)-eicosatetraenoate + 2
CC         glutathione = (12R)-hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoate +
CC         glutathione disulfide + H2O; Xref=Rhea:RHEA:76691, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:75230,
CC         ChEBI:CHEBI:83343; Evidence={ECO:0000269|PubMed:36608588};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76692;
CC         Evidence={ECO:0000305|PubMed:36608588};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-eicosatetraenoate + 2
CC         glutathione = (12S)-hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoate +
CC         glutathione disulfide + H2O; Xref=Rhea:RHEA:50708, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:57444, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297,
CC         ChEBI:CHEBI:90680; Evidence={ECO:0000269|PubMed:11115402,
CC         ECO:0000269|PubMed:36608588};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50709;
CC         Evidence={ECO:0000305|PubMed:11115402};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(15S)-hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoate + 2
CC         glutathione = (15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoate +
CC         glutathione disulfide + H2O; Xref=Rhea:RHEA:76695, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:57409, ChEBI:CHEBI:57446, ChEBI:CHEBI:57925,
CC         ChEBI:CHEBI:58297; Evidence={ECO:0000269|PubMed:36608588};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76696;
CC         Evidence={ECO:0000305|PubMed:36608588};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5S)-hydroperoxy-(6E,8Z,11Z,14Z,17Z)-eicosapentaenoate + 2
CC         glutathione = (5S)-hydroxy-(6E,8Z,11Z,14Z,17Z)-eicosapentaenoate +
CC         glutathione disulfide + H2O; Xref=Rhea:RHEA:76699, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:195399,
CC         ChEBI:CHEBI:195400; Evidence={ECO:0000269|PubMed:36608588};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76700;
CC         Evidence={ECO:0000305|PubMed:36608588};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(12S)-hydroperoxy-(5Z,8Z,10E,14Z,17Z)-eicosapentaenoate + 2
CC         glutathione = (12S)-hydroxy-(5Z,8Z,10E,14Z,17Z)-eicosapentaenoate +
CC         glutathione disulfide + H2O; Xref=Rhea:RHEA:76703, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:90772,
CC         ChEBI:CHEBI:195401; Evidence={ECO:0000269|PubMed:36608588};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76704;
CC         Evidence={ECO:0000305|PubMed:36608588};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(15S)-hydroperoxy-(5Z,8Z,11Z,13E,17Z)-eicosapentaenoate + 2
CC         glutathione = (15S)-hydroxy-(5Z,8Z,11Z,13E,17Z)-eicosapentaenoate +
CC         glutathione disulfide + H2O; Xref=Rhea:RHEA:76707, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:132087,
CC         ChEBI:CHEBI:194369; Evidence={ECO:0000269|PubMed:36608588};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76708;
CC         Evidence={ECO:0000305|PubMed:36608588};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(15S)-hydroperoxy-(11Z,13E)-eicosadienoate + 2 glutathione =
CC         (15S)-hydroxy-(11Z,13E)-eicosadienoate + glutathione disulfide + H2O;
CC         Xref=Rhea:RHEA:76711, ChEBI:CHEBI:15377, ChEBI:CHEBI:57925,
CC         ChEBI:CHEBI:58297, ChEBI:CHEBI:144832, ChEBI:CHEBI:195402;
CC         Evidence={ECO:0000269|PubMed:36608588};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76712;
CC         Evidence={ECO:0000305|PubMed:36608588};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(17S)-hydroperoxy-(4Z,7Z,10Z,13Z,15E,19Z)-docosahexaenoate + 2
CC         glutathione = (17S)-hydroxy-(4Z,7Z,10Z,13Z,15E,19Z)-docosahexaenoate
CC         + glutathione disulfide + H2O; Xref=Rhea:RHEA:76715,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297,
CC         ChEBI:CHEBI:133795, ChEBI:CHEBI:195403;
CC         Evidence={ECO:0000269|PubMed:36608588};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76716;
CC         Evidence={ECO:0000305|PubMed:36608588};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a hydroperoxy-1,2-diacyl-glycero-3-phosphocholine + 2
CC         glutathione = a hydroxy-1,2-diacyl-glycero-3-phosphocholine +
CC         glutathione disulfide + H2O; Xref=Rhea:RHEA:76731, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:195423,
CC         ChEBI:CHEBI:195424; Evidence={ECO:0000269|PubMed:36608588};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76732;
CC         Evidence={ECO:0000305|PubMed:36608588};
CC   -!- SUBUNIT: Monomer. Has a tendency to form higher mass oligomers
CC       (PubMed:17630701). Interacts with FUNDC1; this interaction promotes
CC       GPX4 recruitment into mitochondria through TOM/TIM complex where it is
CC       degraded by mitophagy (PubMed:36828120). {ECO:0000269|PubMed:17630701,
CC       ECO:0000269|PubMed:36828120}.
CC   -!- SUBCELLULAR LOCATION: [Isoform Mitochondrial]: Mitochondrion
CC       {ECO:0000250|UniProtKB:O70325}.
CC   -!- SUBCELLULAR LOCATION: [Isoform Cytoplasmic]: Cytoplasm
CC       {ECO:0000269|PubMed:11115402}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Mitochondrial;
CC         IsoId=P36969-1; Sequence=Displayed;
CC       Name=Cytoplasmic;
CC         IsoId=P36969-2; Sequence=VSP_018740;
CC   -!- TISSUE SPECIFICITY: Present primarily in testis. Expressed in platelets
CC       (at protein level) (PubMed:11115402). {ECO:0000269|PubMed:11115402,
CC       ECO:0000269|PubMed:9705830}.
CC   -!- DISEASE: Spondylometaphyseal dysplasia, Sedaghatian type (SMDS)
CC       [MIM:250220]: A form of spondylometaphyseal dysplasia, a group of short
CC       stature disorders distinguished by abnormalities in the vertebrae and
CC       the metaphyses of the tubular bones. SMDS is a neonatal lethal form
CC       characterized by severe metaphyseal chondrodysplasia with mild limb
CC       shortening, platyspondyly, cardiac conduction defects, and central
CC       nervous system abnormalities. {ECO:0000269|PubMed:24706940}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the glutathione peroxidase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Life, a subtle balance
CC       - Issue 205 of July 2018;
CC       URL="https://www.proteinspotlight.org/back_issues/205/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X71973; CAA50793.1; -; mRNA.
DR   EMBL; AF060972; AAC32261.1; -; Genomic_DNA.
DR   EMBL; AY324108; AAP72965.1; -; Genomic_DNA.
DR   EMBL; AC004151; AAC03239.1; -; Genomic_DNA.
DR   EMBL; AC005390; AAC28920.1; -; Genomic_DNA.
DR   EMBL; BC011836; AAH11836.1; -; mRNA.
DR   EMBL; BC021567; AAH21567.1; -; mRNA.
DR   EMBL; BC022071; AAH22071.1; -; mRNA.
DR   EMBL; BC032695; AAH32695.3; -; mRNA.
DR   EMBL; BC039849; AAH39849.1; -; mRNA.
DR   CCDS; CCDS42457.1; -. [P36969-1]
DR   CCDS; CCDS92476.1; -. [P36969-2]
DR   PIR; T02747; T02747.
DR   RefSeq; NP_001034936.1; NM_001039847.2.
DR   RefSeq; NP_001354761.1; NM_001367832.1. [P36969-2]
DR   RefSeq; NP_002076.2; NM_002085.5. [P36969-1]
DR   PDB; 2GS3; X-ray; 1.90 A; A=36-197.
DR   PDB; 2OBI; X-ray; 1.55 A; A=29-197.
DR   PDB; 5H5Q; X-ray; 1.10 A; A=29-197.
DR   PDB; 5H5R; X-ray; 1.20 A; A=29-197.
DR   PDB; 5H5S; X-ray; 1.85 A; A=29-197.
DR   PDB; 6ELW; X-ray; 1.30 A; A=29-197.
DR   PDB; 6HKQ; X-ray; 1.54 A; A=28-197.
DR   PDB; 6HN3; X-ray; 1.01 A; A=28-197.
DR   PDB; 7L8K; X-ray; 1.38 A; A=30-197.
DR   PDB; 7L8L; X-ray; 1.61 A; A=30-197.
DR   PDB; 7L8M; X-ray; 2.07 A; A=30-197.
DR   PDB; 7L8Q; X-ray; 1.48 A; A=30-197.
DR   PDB; 7L8R; X-ray; 1.52 A; A/B=30-197.
DR   PDB; 7U4I; X-ray; 1.97 A; A/B=30-197.
DR   PDB; 7U4J; X-ray; 1.81 A; A=30-197.
DR   PDB; 7U4K; X-ray; 1.69 A; A=30-197.
DR   PDB; 7U4L; X-ray; 2.25 A; A/B/C/D=30-197.
DR   PDB; 7U4M; X-ray; 1.93 A; A=30-197.
DR   PDB; 7U4N; X-ray; 1.60 A; A/B=30-197.
DR   PDB; 8Q8J; X-ray; 2.00 A; A=41-195.
DR   PDB; 8Q8N; X-ray; 1.90 A; A=28-197.
DR   PDBsum; 2GS3; -.
DR   PDBsum; 2OBI; -.
DR   PDBsum; 5H5Q; -.
DR   PDBsum; 5H5R; -.
DR   PDBsum; 5H5S; -.
DR   PDBsum; 6ELW; -.
DR   PDBsum; 6HKQ; -.
DR   PDBsum; 6HN3; -.
DR   PDBsum; 7L8K; -.
DR   PDBsum; 7L8L; -.
DR   PDBsum; 7L8M; -.
DR   PDBsum; 7L8Q; -.
DR   PDBsum; 7L8R; -.
DR   PDBsum; 7U4I; -.
DR   PDBsum; 7U4J; -.
DR   PDBsum; 7U4K; -.
DR   PDBsum; 7U4L; -.
DR   PDBsum; 7U4M; -.
DR   PDBsum; 7U4N; -.
DR   PDBsum; 8Q8J; -.
DR   PDBsum; 8Q8N; -.
DR   SMR; P36969; -.
DR   BioGRID; 109137; 107.
DR   DIP; DIP-53543N; -.
DR   FunCoup; P36969; 1591.
DR   IntAct; P36969; 32.
DR   MINT; P36969; -.
DR   STRING; 9606.ENSP00000346103; -.
DR   BindingDB; P36969; -.
DR   ChEMBL; CHEMBL4295754; -.
DR   DrugBank; DB09096; Benzoyl peroxide.
DR   DrugBank; DB00143; Glutathione.
DR   DrugBank; DB03310; Glutathione disulfide.
DR   GuidetoPHARMACOLOGY; 3239; -.
DR   SwissLipids; SLP:000001633; -.
DR   MoonProt; P36969; -.
DR   PeroxiBase; 3603; HsGPx04-A.
DR   PeroxiBase; 3632; HsGPx04-B.
DR   PeroxiBase; 3633; HsGPx04-C.
DR   GlyGen; P36969; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P36969; -.
DR   MetOSite; P36969; -.
DR   PhosphoSitePlus; P36969; -.
DR   SwissPalm; P36969; -.
DR   BioMuta; GPX4; -.
DR   DMDM; 172045844; -.
DR   REPRODUCTION-2DPAGE; IPI00304814; -.
DR   jPOST; P36969; -.
DR   MassIVE; P36969; -.
DR   PaxDb; 9606-ENSP00000346103; -.
DR   PeptideAtlas; P36969; -.
DR   ProteomicsDB; 55250; -. [P36969-1]
DR   ProteomicsDB; 55251; -. [P36969-2]
DR   Pumba; P36969; -.
DR   ABCD; P36969; 1 sequenced antibody.
DR   Antibodypedia; 3263; 373 antibodies from 40 providers.
DR   DNASU; 2879; -.
DR   Ensembl; ENST00000354171.13; ENSP00000346103.7; ENSG00000167468.20. [P36969-1]
DR   Ensembl; ENST00000611653.4; ENSP00000483655.1; ENSG00000167468.20. [P36969-2]
DR   GeneID; 2879; -.
DR   KEGG; hsa:2879; -.
DR   MANE-Select; ENST00000354171.13; ENSP00000346103.7; NM_002085.5; NP_002076.2.
DR   UCSC; uc021umg.3; human. [P36969-1]
DR   AGR; HGNC:4556; -.
DR   CTD; 2879; -.
DR   DisGeNET; 2879; -.
DR   GeneCards; GPX4; -.
DR   HGNC; HGNC:4556; GPX4.
DR   HPA; ENSG00000167468; Low tissue specificity.
DR   MalaCards; GPX4; -.
DR   MIM; 138322; gene.
DR   MIM; 250220; phenotype.
DR   OpenTargets; ENSG00000167468; -.
DR   Orphanet; 93317; Spondylometaphyseal dysplasia, Sedaghatian type.
DR   VEuPathDB; HostDB:ENSG00000167468; -.
DR   eggNOG; KOG1651; Eukaryota.
DR   GeneTree; ENSGT00940000161913; -.
DR   InParanoid; P36969; -.
DR   OMA; TFPMTEK; -.
DR   OrthoDB; 446890at2759; -.
DR   PAN-GO; P36969; 4 GO annotations based on evolutionary models.
DR   PhylomeDB; P36969; -.
DR   BioCyc; MetaCyc:HS09562-MONOMER; -.
DR   BRENDA; 1.11.1.12; 2681.
DR   PathwayCommons; P36969; -.
DR   Reactome; R-HSA-2142688; Synthesis of 5-eicosatetraenoic acids.
DR   Reactome; R-HSA-2142712; Synthesis of 12-eicosatetraenoic acid derivatives.
DR   Reactome; R-HSA-2142770; Synthesis of 15-eicosatetraenoic acid derivatives.
DR   Reactome; R-HSA-9018676; Biosynthesis of D-series resolvins. [P36969-2]
DR   Reactome; R-HSA-9018896; Biosynthesis of E-series 18(S)-resolvins. [P36969-2]
DR   Reactome; R-HSA-9020265; Biosynthesis of aspirin-triggered D-series resolvins. [P36969-2]
DR   Reactome; R-HSA-9023661; Biosynthesis of E-series 18(R)-resolvins. [P36969-2]
DR   SABIO-RK; P36969; -.
DR   SignaLink; P36969; -.
DR   BioGRID-ORCS; 2879; 428 hits in 1164 CRISPR screens.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; GPX4; human.
DR   EvolutionaryTrace; P36969; -.
DR   GeneWiki; GPX4; -.
DR   GenomeRNAi; 2879; -.
DR   Pharos; P36969; Tchem.
DR   PRO; PR:P36969; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P36969; protein.
DR   Bgee; ENSG00000167468; Expressed in left testis and 203 other cell types or tissues.
DR   ExpressionAtlas; P36969; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; HTP:FlyBase.
DR   GO; GO:0005635; C:nuclear envelope; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IMP:CAFA.
DR   GO; GO:0004602; F:glutathione peroxidase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IMP:CAFA.
DR   GO; GO:0047066; F:phospholipid-hydroperoxide glutathione peroxidase activity; IDA:UniProtKB.
DR   GO; GO:0008430; F:selenium binding; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; IEA:Ensembl.
DR   GO; GO:0019369; P:arachidonate metabolic process; IDA:UniProtKB.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0006325; P:chromatin organization; IEA:Ensembl.
DR   GO; GO:0016358; P:dendrite development; IEA:Ensembl.
DR   GO; GO:0019372; P:lipoxygenase pathway; IDA:UniProtKB.
DR   GO; GO:0042759; P:long-chain fatty acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0110076; P:negative regulation of ferroptosis; ISS:UniProtKB.
DR   GO; GO:0006644; P:phospholipid metabolic process; TAS:UniProtKB.
DR   GO; GO:0051258; P:protein polymerization; IMP:CAFA.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0006979; P:response to oxidative stress; ISS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB.
DR   CDD; cd00340; GSH_Peroxidase; 1.
DR   FunFam; 3.40.30.10:FF:000111; Glutathione peroxidase; 1.
DR   Gene3D; 3.40.30.10; Glutaredoxin; 1.
DR   InterPro; IPR000889; Glutathione_peroxidase.
DR   InterPro; IPR029759; GPX_AS.
DR   InterPro; IPR029760; GPX_CS.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   PANTHER; PTHR11592; GLUTATHIONE PEROXIDASE; 1.
DR   PANTHER; PTHR11592:SF134; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; 1.
DR   Pfam; PF00255; GSHPx; 1.
DR   PIRSF; PIRSF000303; Glutathion_perox; 1.
DR   SUPFAM; SSF52833; Thioredoxin-like; 1.
DR   PROSITE; PS00460; GLUTATHIONE_PEROXID_1; 1.
DR   PROSITE; PS00763; GLUTATHIONE_PEROXID_2; 1.
DR   PROSITE; PS51355; GLUTATHIONE_PEROXID_3; 1.
DR   neXtProt; NX_P36969; -.
DR   PharmGKB; PA28952; -.
DR   TreeFam; TF338735; -.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative initiation; Cytoplasm; Developmental protein;
KW   Dwarfism; Lipid metabolism; Mitochondrion; Oxidoreductase; Peroxidase;
KW   Phosphoprotein; Proteomics identification; Reference proteome;
KW   Selenocysteine; Transit peptide.
FT   TRANSIT         1..?
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           ?..197
FT                   /note="Phospholipid hydroperoxide glutathione peroxidase
FT                   GPX4"
FT                   /id="PRO_0000013067"
FT   ACT_SITE        73
FT                   /evidence="ECO:0000250|UniProtKB:O70325"
FT   NON_STD         73
FT                   /note="Selenocysteine"
FT                   /evidence="ECO:0000305|PubMed:8039723,
FT                   ECO:0000305|PubMed:9705830"
FT   MOD_RES         40
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P36970"
FT   VAR_SEQ         1..27
FT                   /note="Missing (in isoform Cytoplasmic)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_018740"
FT   VARIANT         2
FT                   /note="S -> N (in dbSNP:rs8178967)"
FT                   /evidence="ECO:0000269|PubMed:12606444, ECO:0000269|Ref.3"
FT                   /id="VAR_017063"
FT   VARIANT         90..197
FT                   /note="Missing (in SMDS)"
FT                   /evidence="ECO:0000269|PubMed:24706940"
FT                   /id="VAR_080140"
FT   VARIANT         120
FT                   /note="A -> T (in a patient affected by cryptorchidism;
FT                   dbSNP:rs76201145)"
FT                   /evidence="ECO:0000269|PubMed:12606444"
FT                   /id="VAR_017064"
FT   MUTAGEN         73
FT                   /note="U->A: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:17630701"
FT   MUTAGEN         73
FT                   /note="U->C: Almost complete loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:17630701"
FT   TURN            35..37
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   HELIX           41..43
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   STRAND          45..48
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   STRAND          53..55
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   HELIX           56..59
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   STRAND          62..69
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   STRAND          71..73
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   HELIX           76..90
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   HELIX           91..93
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   STRAND          95..101
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   TURN            104..107
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   HELIX           113..121
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   TURN            122..124
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   STRAND          127..130
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   STRAND          135..137
FT                   /evidence="ECO:0007829|PDB:7U4J"
FT   HELIX           142..149
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   HELIX           151..153
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   STRAND          158..160
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   STRAND          167..170
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   STRAND          176..180
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   HELIX           186..192
FT                   /evidence="ECO:0007829|PDB:6HN3"
FT   HELIX           195..197
FT                   /evidence="ECO:0007829|PDB:6HN3"
SQ   SEQUENCE   197 AA;  22175 MW;  1AE3BC7AE42FDDB1 CRC64;
     MSLGRLCRLL KPALLCGALA APGLAGTMCA SRDDWRCARS MHEFSAKDID GHMVNLDKYR
     GFVCIVTNVA SQUGKTEVNY TQLVDLHARY AECGLRILAF PCNQFGKQEP GSNEEIKEFA
     AGYNVKFDMF SKICVNGDDA HPLWKWMKIQ PKGKGILGNA IKWNFTKFLI DKNGCVVKRY
     GPMEEPLVIE KDLPHYF
//
